LATEST ALERTSIntoxicating hemp-derived cannabinoids (IHDC) have been major disruptors in the CBD and legal cannabis sectors in the US for some time now. This report details and analyses recent developments in their regulation
Government officials in Guyana believe the Industrial Hemp Bill, expected to be voted on by Parliament by the end of June, will be a big step towards the creation of a legal framework for hemp cultivation and manufacturing
A new law makes Minnesota the first state in the US to apply a 21+ age restriction to all hemp-derived cannabinoid products regardless of potential for intoxication
Germany should plan ahead to avoid problems which have plagued governments that have already legalised recreational cannabis on top of medical cannabis
US firm 22nd Century has begun integration with GVB Biopharma, one of the largest CBD suppliers globally, as part of a plan to grow its hemp/cannabis franchise rapidly
Companies are trying new ways to reach cannabinoid customers in severely restricted Australia, but they must be careful not to fall foul of strict guidelines that separate promoting from simply informing the public about prescription goods
A hold has been placed on European novel food assessment after the European Food Safety Authority (EFSA) said it was unable to proceed due to identified knowledge gaps in safety data
Spending on CBD- and cannabis-related lobbying in the US exceeded pre-pandemic numbers, with more than $12m spent during the first quarter of 2022 on issues such as efforts to support patient safety, legalisation and decriminalisation
The US Food and Drug Administration (FDA) has issued warnings to four companies that have sold veterinary products containing CBD
This report offers a comprehensive overview of the current regulatory framework in Paraguay for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes
The need to improve sleep is one of the main reasons why US consumers buy CBD, according to CBD-Intel’s latest market research; however, a recent report from a CBD watchdog claims that 60% of the CBD products marketed as sleep aids do not contain the amounts of CBD, cannabinol (CBN) and/or melatonin stated on the product labels
This report sets out to guide you through the legal status and classification of two of the most popular cannabinoids, after CBD and THC, in 50 selected countries
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
